Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Why End Users are Driving Innovation in UCC with Scott Wharton of Logitech

How should the AV industry develop new solutions to drive technology and innovations in their markets? Here is an often forgotten secret, it should focus on the end user. In emerging markets such as hospitality, healthcare, and education, the demands from the end user help drive these innovations. Scott Wharton, VP & GM, Video…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Pro AV Today on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

How should the AV industry develop new solutions to drive technology and innovations in their markets? Here is an often forgotten secret, it should focus on the end user. In emerging markets such as hospitality, healthcare, and education, the demands from the end user help drive these innovations. Scott Wharton, VP & GM, Video Collaboration Group at Logitech, spoke with Ben Thomas on what end-user trends are driving innovation in VCC (video conferencing and collaboration) and UCC (unified communications and collaboration.)

Wharton said the past couple of years shifted the conversation from should I be using video conferencing to how should I be using it. “And the pandemic and hybrid work has uncovered all these new scenarios and use cases where it’s actually harder, and things broke, and we need to relook at things and do it differently.”

What is exciting about these emerging markets is the opportunity to learn new things from end users who are not traditional AV users. It’s no longer only about providing video solutions for large conference and board rooms. Today, organizations recognize the need for video capabilities everywhere. Customization and expense are out; scale is what’s required. And with more end-user interaction with the technology, these solutions need to be accessible and easy to use.

One size does not fit all is undoubtedly apropos in today’s end-user-driven UCC world. Wharton said solutions need to accommodate much smaller rooms and areas than they did pre-pandemic. “There are now focus rooms where maybe it’s just two-to-three people, and maybe one. That might need a different solution, where now there are these rec rooms or breakout rooms where you can’t have it fixed or nailed down. So, there’s an emphasis on modularity, putting stuff on wheels, and moving things around.”

Pro AV Today

Part of this channel

Pro AV Today

Pro AV news, trends, and expert voices for the AV industry

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512